A detailed history of Bulltick Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bulltick Wealth Management, LLC holds 19,282 shares of VRTX stock, worth $9.15 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares
19,282
Previous 19,912 3.16%
Holding current value
$9.15 Million
Previous $8.1 Billion 0.52%
% of portfolio
1.38%
Previous 1.84%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $256,844 - $281,030
-630 Reduced 3.16%
19,282 $8.06 Billion
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $6.83 Million - $8.18 Million
19,912 New
19,912 $8.1 Billion
Q3 2023

Apr 24, 2024

SELL
$338.18 - $362.46 $314,507 - $337,087
-930 Reduced 4.34%
20,477 $7.12 Billion
Q2 2023

Apr 24, 2024

SELL
$314.42 - $351.91 $44,018 - $49,267
-140 Reduced 0.65%
21,407 $7.53 Billion
Q1 2023

Apr 24, 2024

SELL
$283.23 - $323.1 $2.18 Million - $2.48 Million
-7,689 Reduced 26.3%
21,547 $6.79 Billion
Q4 2022

Apr 24, 2024

SELL
$285.76 - $321.48 $1.59 Million - $1.79 Million
-5,555 Reduced 15.97%
29,236 $8.44 Billion
Q3 2022

Apr 24, 2024

SELL
$273.83 - $305.53 $1,916 - $2,138
-7 Reduced 0.02%
34,791 $10.1 Billion
Q1 2022

Apr 24, 2024

SELL
$221.42 - $260.97 $1.19 Million - $1.4 Million
-5,374 Reduced 13.38%
34,798 $9.08 Billion
Q4 2021

Apr 24, 2024

SELL
$177.01 - $223.45 $379,863 - $479,523
-2,146 Reduced 5.07%
40,172 $8.82 Billion
Q3 2021

Apr 24, 2024

SELL
$181.39 - $202.99 $285,689 - $319,709
-1,575 Reduced 3.59%
42,318 $7.68 Billion
Q2 2021

Apr 24, 2024

BUY
$187.49 - $221.1 $7.86 Million - $9.27 Million
41,906 Added 2109.01%
43,893 $8.85 Billion
Q1 2021

Apr 24, 2024

BUY
$207.02 - $241.31 $150,710 - $175,673
728 Added 57.82%
1,987 $427 Million
Q4 2020

Apr 24, 2024

SELL
$207.01 - $276.09 $3.86 Million - $5.15 Million
-18,653 Reduced 93.68%
1,259 $298 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Bulltick Wealth Management, LLC Portfolio

Follow Bulltick Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bulltick Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bulltick Wealth Management, LLC with notifications on news.